Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Rosaria Rizzo

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Aging and Disease|April 5, 2021
SARS-CoV-2 Emergency and Long-Term Cognitive Impairment in Older PeopleMaria Rosaria Rizzo, Giuseppe Paolisso
Diabetes Research and Clinical Practice|May 3, 2026
DPP-4 inhibitors in current diabetes care: their foundational role in treating to targetAngelo Avogaro, Enrico Fiaccadori, Maria Rosaria Rizzo
International Journal of Molecular Sciences|March 20, 2020
Adiponectin and Cognitive DeclineMaria Rosaria Rizzo, Renata Fasano, Giuseppe Paolisso
Diabetes Care|June 13, 2012
Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibitionMaria Rosaria Rizzo, Michelangela Barbieri, Raffaele Marfella, et al.
Biomedicines|March 29, 2023
Alzheimer's Disease from the Amyloidogenic Theory to the Puzzling Crossroads between Vascular, Metabolic and Energetic Maladaptive PlasticityMichele Cerasuolo, Michele Papa, Anna Maria Colangelo, et al.
International Journal of Surgery (London, England)|July 1, 2015
Pancreatic cancer and diabetes: A two-way relationship in the perspective of diabetologistTeresa Salvatore, Raffaele Marfella, Maria Rosaria Rizzo, et al.
Advances in Therapy|March 14, 2012
Dipeptidyl peptidase-4 inhibitors in the elderly: more benefits or risks?Giuseppe Paolisso, Matteo Monami, Raffaele Marfella, et al.
Age (Dordrecht, Netherlands)|July 9, 2013
Short-term effects of low-dose estrogen/drospirenone vs low-dose estrogen/dydrogesterone on glycemic fluctuations in postmenopausal women with metabolic syndromeMaria Rosaria Rizzo, Stefania Leo, Pasquale De Franciscis, et al.
Epilepsy & Behavior Case Reports|June 24, 2015
The ictal bradycardia syndrome: A case reportIlaria Fava, Salvatore Del Gaudio, Enrico Volpe, et al.
Plos One|August 27, 2013
Association of genetic variation in adaptor protein APPL1/APPL2 loci with non-alcoholic fatty liver diseaseMichelangela Barbieri, Antonietta Esposito, Edith Angellotti, et al.
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Aging and Disease|April 5, 2021
SARS-CoV-2 Emergency and Long-Term Cognitive Impairment in Older PeopleMaria Rosaria Rizzo, Giuseppe Paolisso
Diabetes Research and Clinical Practice|May 3, 2026
DPP-4 inhibitors in current diabetes care: their foundational role in treating to targetAngelo Avogaro, Enrico Fiaccadori, Maria Rosaria Rizzo
International Journal of Molecular Sciences|March 20, 2020
Adiponectin and Cognitive DeclineMaria Rosaria Rizzo, Renata Fasano, Giuseppe Paolisso
Diabetes Care|June 13, 2012
Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibitionMaria Rosaria Rizzo, Michelangela Barbieri, Raffaele Marfella, et al.
Biomedicines|March 29, 2023
Alzheimer's Disease from the Amyloidogenic Theory to the Puzzling Crossroads between Vascular, Metabolic and Energetic Maladaptive PlasticityMichele Cerasuolo, Michele Papa, Anna Maria Colangelo, et al.
International Journal of Surgery (London, England)|July 1, 2015
Pancreatic cancer and diabetes: A two-way relationship in the perspective of diabetologistTeresa Salvatore, Raffaele Marfella, Maria Rosaria Rizzo, et al.
Advances in Therapy|March 14, 2012
Dipeptidyl peptidase-4 inhibitors in the elderly: more benefits or risks?Giuseppe Paolisso, Matteo Monami, Raffaele Marfella, et al.
Age (Dordrecht, Netherlands)|July 9, 2013
Short-term effects of low-dose estrogen/drospirenone vs low-dose estrogen/dydrogesterone on glycemic fluctuations in postmenopausal women with metabolic syndromeMaria Rosaria Rizzo, Stefania Leo, Pasquale De Franciscis, et al.
Epilepsy & Behavior Case Reports|June 24, 2015
The ictal bradycardia syndrome: A case reportIlaria Fava, Salvatore Del Gaudio, Enrico Volpe, et al.
Plos One|August 27, 2013
Association of genetic variation in adaptor protein APPL1/APPL2 loci with non-alcoholic fatty liver diseaseMichelangela Barbieri, Antonietta Esposito, Edith Angellotti, et al.
Pageof 10